Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report

Tyrosine kinase inhibitors (TKIs) have transformed the standard of care in lung cancer. A number of TKIs have been discovered that specifically target oncogenes, including MET receptor tyrosine kinase. Second-generation MET TKIs are showing improved efficacy over first-generation TKIs. Herein, we re...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, Katherine G., Mambetsariev, Isa, Salgia, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784494/
https://www.ncbi.nlm.nih.gov/pubmed/33335011
http://dx.doi.org/10.1101/mcs.a005785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784494/
https://www.ncbi.nlm.nih.gov/pubmed/33335011
http://dx.doi.org/10.1101/mcs.a005785

Ejemplares similares